Logo image of VPI.CA

VITALITY PRODUCTS INC (VPI.CA) Stock Fundamental Analysis

TSX-V:VPI - TSX Venture Exchange - CA92847D1050 - Common Stock - Currency: CAD

0.03  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to VPI. VPI was compared to 4 industry peers in the Personal Care Products industry. VPI has a bad profitability rating. Also its financial health evaluation is rather negative. VPI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year VPI has reported negative net income.
In the past year VPI has reported a negative cash flow from operations.
In the past 5 years VPI always reported negative net income.
In the past 5 years VPI always reported negative operating cash flow.
VPI.CA Yearly Net Income VS EBIT VS OCF VS FCFVPI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K -600K

1.2 Ratios

VPI has a Return On Assets (-23.60%) which is in line with its industry peers.
Industry RankSector Rank
ROA -23.6%
ROE N/A
ROIC N/A
ROA(3y)-38.32%
ROA(5y)-27.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VPI.CA Yearly ROA, ROE, ROICVPI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

VPI has a Gross Margin of 72.30%. This is amongst the best in the industry. VPI outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of VPI has remained more or less at the same level.
VPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y0.07%
VPI.CA Yearly Profit, Operating, Gross MarginsVPI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1

2. Health

2.1 Basic Checks

VPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VPI remains at a similar level compared to 1 year ago.
VPI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for VPI has been reduced compared to a year ago.
VPI.CA Yearly Shares OutstandingVPI.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VPI.CA Yearly Total Debt VS Total AssetsVPI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

2.2 Solvency

Based on the Altman-Z score of -30.28, we must say that VPI is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of VPI (-30.28) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -30.28
ROIC/WACCN/A
WACC7.56%
VPI.CA Yearly LT Debt VS Equity VS FCFVPI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500K -1M -1.5M

2.3 Liquidity

VPI has a Current Ratio of 0.21. This is a bad value and indicates that VPI is not financially healthy enough and could expect problems in meeting its short term obligations.
VPI has a Current ratio of 0.21. This is comparable to the rest of the industry: VPI outperforms 50.00% of its industry peers.
VPI has a Quick Ratio of 0.21. This is a bad value and indicates that VPI is not financially healthy enough and could expect problems in meeting its short term obligations.
VPI has a Quick ratio (0.16) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.21
Quick Ratio 0.16
VPI.CA Yearly Current Assets VS Current LiabilitesVPI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

3

3. Growth

3.1 Past

VPI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.49%, which is quite impressive.
Looking at the last year, VPI shows a decrease in Revenue. The Revenue has decreased by -5.91% in the last year.
VPI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.32% yearly.
EPS 1Y (TTM)53.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-5.91%
Revenue growth 3Y-1.67%
Revenue growth 5Y8.32%
Sales Q2Q%-16.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VPI.CA Yearly Revenue VS EstimatesVPI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
VPI.CA Price Earnings VS Forward Price EarningsVPI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VPI.CA Per share dataVPI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for VPI!.
Industry RankSector Rank
Dividend Yield N/A

VITALITY PRODUCTS INC

TSX-V:VPI (6/4/2025, 7:00:00 PM)

0.03

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-28 2025-05-28
Earnings (Next)06-25 2025-06-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners20.45%
Ins Owner ChangeN/A
Market Cap1.24M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.7
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.02
BVpS-0.04
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.6%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.3%
FCFM N/A
ROA(3y)-38.32%
ROA(5y)-27.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y0.07%
F-Score4
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.21
Quick Ratio 0.16
Altman-Z -30.28
F-Score4
WACC7.56%
ROIC/WACCN/A
Cap/Depr(3y)52.06%
Cap/Depr(5y)40.57%
Cap/Sales(3y)0.58%
Cap/Sales(5y)0.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.91%
Revenue growth 3Y-1.67%
Revenue growth 5Y8.32%
Sales Q2Q%-16.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y55.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y94.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.18%
OCF growth 3YN/A
OCF growth 5YN/A